Table 1.

Melanoma prognosis depends on immune cell composition and localization.

Immune cells	Localization	Prognostic impact	References
Conventional CD4+ and CD8+ T lymphocytes	Primary tumor	Good and Bad	32,35,36,87
	Metastases	Good and Bad	29,42
Regulatory T cells	Primary tumor	Bad/No impact	37-39,47
	Metastases	Bad/No impact	29,37,39-42
B lymphocytes	Primary tumor	Good	77,78
	Metastases	Good	29
Plasmocytes	Primary tumor	Bad	79
	Metastases	Good	29
NK cells	Primary tumor	Good	96
	Metastases	Good	97,98
MDSC	Primary tumor	Bad	83
	Metastases	Bad	42,83
Plasmacytoid DC	Primary tumor	Bad	35,82
	Metastases	Bad	81
DC	Primary tumor	Good	35,87
	Metastases	Good/No impact	29,89
Macrophages	Primary tumor	Bad	88
	Metastases	Bad/No impact	29,89
Neutrophils	Primary tumor	Bad	35
Mastocytes	Primary tumor	Bad	80